RY 169.51 -1.1719% SHOP 175.85 -3.2036% TD 85.4 -0.187% ENB 59.6 -1.715% BN 84.78 -1.4873% TRI 250.65 2.1186% CNQ 43.69 0.9007% CP 110.72 -0.5926% CNR 146.88 0.7891% BMO 142.84 -0.6054% BNS 72.34 -0.0829% CSU 4896.4902 0.1981% CM 87.07 -0.9668% MFC 45.08 6.5217% ATD 71.13 -0.6425% NGT 68.13 0.9932% TRP 64.42 -1.2872% SU 56.73 -0.0176% WCN 266.69 -0.146% L 176.74 -1.5157%
Last update at 2025-02-20T19:13:00Z
Philip Morris International Presents at 2025 CAGNY Conference; Reaffirms 2025 Full-Year Forecast
Wed 19 Feb 25, 01:45 PMIs Philip Morris International Inc. (PM) the Best Performing S&P 500 Stock So Far In 2025?
Mon 17 Feb 25, 09:11 PMLee Ainslie's Strategic Moves: Advanced Micro Devices Inc. Sees Significant Reduction
Fri 14 Feb 25, 11:29 PMSteve Mandel's Strategic Moves: A Closer Look at Eli Lilly and Co's 4.49% Portfolio Impact
Fri 14 Feb 25, 11:28 PMIndian benchmarks set to open higher after Modi agrees to trade negotiations with Trump
Fri 14 Feb 25, 03:18 AM11 Tariff-Proof Dividend Stocks
Thu 13 Feb 25, 07:00 AMTom Russo's Strategic Moves: A Closer Look at Berkshire Hathaway Inc's Portfolio Impact
Wed 12 Feb 25, 06:18 PMPhilip Morris International to Present at 2025 CAGNY Conference
Wed 12 Feb 25, 05:07 PMPhilip Morris International (PM) Among the Best FMCG Stocks to Buy According to Hedge Funds
Sat 08 Feb 25, 10:57 PMIndian PM Modi to visit US from February 12-13, to hold talks with Trump
Fri 07 Feb 25, 11:44 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 11634.00M | 12232.00M | 10953.00M | 9872.00M | 10671.00M |
| Minority interest | 479.00M | 601.00M | 536.00M | 543.00M | 1720.00M |
| Net income | 9048.00M | 9109.00M | 8056.00M | 7185.00M | 7911.00M |
| Selling general administrative | 8138.00M | 8419.00M | 7481.00M | 8784.00M | 7449.00M |
| Selling and marketing expenses | - | 8304.00M | 7384.00M | 8695.00M | 7408.00M |
| Gross profit | 20360.00M | 21375.00M | 19125.00M | 19292.00M | 18867.00M |
| Reconciled depreciation | 1189.00M | 96.00M | 981.00M | 964.00M | 989.00M |
| Ebit | 12246.00M | 12975.00M | 11668.00M | 10531.00M | 11336.00M |
| Ebitda | 12222.00M | 12956.00M | 11644.00M | 10508.00M | 11418.00M |
| Depreciation and amortization | -24.00000M | -19.00000M | -24.00000M | -23.00000M | 82.00M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 12246.00M | 12975.00M | 11668.00M | 10531.00M | 11377.00M |
| Other operating expenses | 19540.00M | 18545.00M | 17123.00M | 19363.00M | 18289.00M |
| Interest expense | 588.00M | 628.00M | 618.00M | 570.00M | 665.00M |
| Tax provision | 2244.00M | 2671.00M | 2377.00M | 2293.00M | 2445.00M |
| Interest income | 588.00M | 628.00M | 618.00M | 226.00M | 190.00M |
| Net interest income | -588.00000M | -628.00000M | -618.00000M | -570.00000M | -665.00000M |
| Extraordinary items | - | - | - | - | -31.00000M |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 2244.00M | 2671.00M | 2377.00M | 2293.00M | 2445.00M |
| Total revenue | 31762.00M | 31405.00M | 28694.00M | 29805.00M | 29625.00M |
| Total operating expenses | 8138.00M | 8515.00M | 7554.00M | 8850.00M | 7531.00M |
| Cost of revenue | 11402.00M | 10030.00M | 9569.00M | 10513.00M | 10758.00M |
| Total other income expense net | -612.00000M | -743.00000M | -715.00000M | -659.00000M | -41.00000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 9390.00M | 9561.00M | 8576.00M | 7579.00M | 8286.00M |
| Net income applicable to common shares | 9048.00M | 9083.00M | 8056.00M | 7185.00M | 7895.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 61681.00M | 41290.00M | 44815.00M | 42875.00M | 39801.00M |
| Intangible assets | 6732.00M | 2818.00M | 2019.00M | 2113.00M | 2278.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 16412.00M | 13221.00M | 14212.00M | 13653.00M | 12849.00M |
| Total liab | 67992.00M | 49498.00M | 55446.00M | 52474.00M | 50540.00M |
| Total stockholder equity | -8957.00000M | -10106.00000M | -12567.00000M | -11577.00000M | -12459.00000M |
| Deferred long term liab | 1956.00M | 726.00M | 684.00M | 908.00M | 898.00M |
| Other current liab | 15012.00M | 16232.00M | 16247.00M | 14444.00M | 12407.00M |
| Common stock | 0.00000M | -10106.00000M | -12567.00000M | 0.00000M | -12459.00000M |
| Capital stock | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Retained earnings | 34289.00M | 33082.00M | 31638.00M | 30987.00M | 31014.00M |
| Other liab | 5345.00M | 5460.00M | 7663.00M | 6416.00M | 6374.00M |
| Good will | 19655.00M | 6680.00M | 5964.00M | 5858.00M | 7189.00M |
| Other assets | 17301.00M | 21128.00M | 4177.00M | 2358.00M | 2422.00M |
| Cash | 3207.00M | 4496.00M | 7280.00M | 6861.00M | 6593.00M |
| Cash and equivalents | 3207.00M | 4496.00M | 7280.00M | 6861.00M | 6593.00M |
| Total current liabilities | 27336.00M | 19255.00M | 19615.00M | 18833.00M | 17191.00M |
| Current deferred revenue | - | -3331.00000M | -2780.00000M | -2299.00000M | -2068.00000M |
| Net debt | 39916.00M | 23310.00M | 24256.00M | 24184.00M | 25166.00M |
| Short term debt | 8248.00M | 3023.00M | 3368.00M | 4389.00M | 4784.00M |
| Short long term debt | 8248.00M | 3023.00M | 3368.00M | 4389.00M | 4784.00M |
| Short long term debt total | 43123.00M | 27806.00M | 31536.00M | 31045.00M | 31759.00M |
| Other stockholder equity | -33687.00000M | -33611.00000M | -33024.00000M | -33201.00000M | -33362.00000M |
| Property plant equipment | 15443.00M | 6168.00M | 6365.00M | 6631.00M | 7201.00M |
| Total current assets | 19619.00M | 17717.00M | 21492.00M | 20514.00M | 19442.00M |
| Long term investments | 4431.00M | 4463.00M | 4798.00M | 4635.00M | 1269.00M |
| Net tangible assets | -8957.00000M | -10106.00000M | -20550.00000M | -19548.00000M | -21926.00000M |
| Short term investments | - | - | 4798.00M | - | - |
| Net receivables | 4756.00M | 3940.00M | 3761.00M | 3717.00M | 3564.00M |
| Long term debt | 34855.00M | 24783.00M | 28168.00M | 26656.00M | 26975.00M |
| Inventory | 9886.00M | 8720.00M | 9591.00M | 9235.00M | 8804.00M |
| Accounts payable | 4076.00M | 3331.00M | 2780.00M | 2299.00M | 2068.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | 2646.00M | 1898.00M | 1936.00M | 1978.00M | 1720.00M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -9559.00000M | -9577.00000M | -11181.00000M | -9363.00000M | -10111.00000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | 34289.00M | 33082.00M | 31638.00M | 30987.00M | 31014.00M |
| Treasury stock | -35917.00000M | -35836.00000M | -35129.00000M | -35220.00000M | -35301.00000M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 3931.00M | 2549.00M | 2767.00M | 1971.00M | 1445.00M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 42062.00M | 23573.00M | 23323.00M | 22361.00M | 20359.00M |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | 34875.00M | 24783.00M | 28168.00M | 26656.00M | 26975.00M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | 264.00M | 432.00M | -598.00000M | 355.00M | 353.00M |
| Change to liabilities | 2320.00M | 1016.00M | 267.00M | 1634.00M | 724.00M |
| Total cashflows from investing activities | -15679.00000M | -2358.00000M | -1154.00000M | -1811.00000M | -998.00000M |
| Net borrowings | 14176.00M | -3042.00000M | -356.00000M | -543.00000M | -2229.00000M |
| Total cash from financing activities | 3806.00M | -11977.00000M | -8496.00000M | -8061.00000M | -9651.00000M |
| Change to operating activities | 1862.00M | 623.00M | 121.00M | 1108.00M | 910.00M |
| Net income | 9527.00M | 9710.00M | 8592.00M | 7728.00M | 8286.00M |
| Change in cash | -1283.00000M | -2785.00000M | 420.00M | 245.00M | -1856.00000M |
| Begin period cash flow | 4500.00M | 7285.00M | 6865.00M | 6620.00M | 8476.00M |
| End period cash flow | 3217.00M | 4500.00M | 7285.00M | 6865.00M | 6620.00M |
| Total cash from operating activities | 10803.00M | 11967.00M | 9812.00M | 10090.00M | 9478.00M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 1189.00M | 998.00M | 981.00M | 964.00M | 989.00M |
| Other cashflows from investing activities | -14866.00000M | -2042.00000M | 46.00M | -1314.00000M | 85.00M |
| Dividends paid | -7812.00000M | -7580.00000M | -7364.00000M | -7161.00000M | 6885.00M |
| Change to inventory | -1287.00000M | 549.00M | -165.00000M | -548.00000M | -613.00000M |
| Change to account receivables | -871.00000M | -198.00000M | 26.00M | -331.00000M | 53.00M |
| Sale purchase of stock | -209.00000M | -775.00000M | - | 51.00M | -81.00000M |
| Other cashflows from financing activities | 19346.00M | -580.00000M | 2982.00M | 4451.00M | -282.00000M |
| Change to netincome | -327.00000M | -308.00000M | -259.00000M | 30.00M | -210.00000M |
| Capital expenditures | 1077.00M | 748.00M | 602.00M | 852.00M | 1436.00M |
| Change receivables | -871.00000M | -198.00000M | 26.00M | -331.00000M | 53.00M |
| Cash flows other operating | 252.00M | 200.00M | 370.00M | 613.00M | 249.00M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | -1070.00000M | -2368.00000M | 162.00M | 218.00M | -1171.00000M |
| Change in working capital | 162.00M | 1367.00M | 128.00M | 755.00M | 164.00M |
| Stock based compensation | - | -22.00000M | -14.00000M | 371.00M | - |
| Other non cash items | 159.00M | -69.00000M | 268.00M | 413.00M | 139.00M |
| Free cash flow | 9726.00M | 11219.00M | 9210.00M | 9238.00M | 8042.00M |
Sector: Consumer Defensive Industry: Tobacco
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PM Philip Morris International Inc |
2.06 1.38% | 151.87 | 18.05 | 14.08 | 4.17 | - | 5.47 | 13.66 |
| BTAFF British American Tobacco p.l.c |
- -% | 37.46 | - | 7.91 | 3.31 | 1.20 | 3.79 | 10.29 |
| BTI British American Tobacco p.l.c. |
0.14 0.38% | 38.55 | - | 7.99 | 3.19 | 1.21 | 3.78 | 10.26 |
| MO Altria Group |
0.81 1.52% | 54.15 | 8.24 | 8.09 | 3.47 | 27.30 | 4.61 | 7.77 |
| JAPAY Japan Tobacco ADR |
0.15 1.23% | 12.34 | 13.91 | 14.62 | 0.02 | 1.68 | 0.02 | 0.05 |
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness and healthcare products. Philip Morris International Inc. was incorporated in 1987 and is headquartered in Stamford, Connecticut.
120 Park Avenue, New York, NY, United States, 10017-5592
| Name | Title | Year Born |
|---|---|---|
| Mr. Andre Calantzopoulos | Exec. Chairman | 1958 |
| Mr. Jacek Olczak | CEO & Director | 1965 |
| Mr. Emmanuel Babeau | Chief Financial Officer | 1967 |
| Mr. Frederic de Wilde | Pres of European Union Region | 1967 |
| Mr. Drago Azinovic | Pres of Middle East & Africa Region and PMI Duty Free | 1962 |
| Mr. Stefano Volpetti | Pres of Smoke-Free Products Category & Chief Consumer Officer | 1972 |
| Dr. Jorge Insuasty M.D. | Chief Life Sciences Officer | 1959 |
| Mr. Massimo Andolina | Sr. VP of Operations | 1969 |
| Mr. Frank De Rooij | VP of Treasury & Corp. Fin. | 1966 |
| Prof. Manuel C. Peitsch | Chief Science Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA 
AU
UK
US
NZ
Please wait processing your request...